Global chemical firm Ashland is now squarely positioned to strengthen its presence in the nutraceutical market after setting up a new business unit, called Ashland Health and Wellness, dedicated to food, beverage, and nutraceuticals.
Milwaukee-based Lakeview Equity Partners, the private equity fund that acquired probiotic manufacturer UAS Labs in 2013, is expanding its reach in the nutraceutical space with an investment in Trumbull, CT-based NutriScience Innovations, a global supplier...
California-based Nellson Nutraceutical has acquired Utah-based Genysis Brand Solutions for an undisclosed sum, expanding the former’s capacity in manufacturing functional powders for beverages and bars.
Rosewood Private Investments, private equity arm of philanthropist and former hotelier Caroline Hunt’s estate, purchased ProTec Laboratory, an East Texas contract manufacturer of dietary supplements, sports nutrition, and pet care products, for an undisclosed...
Ingredient giant DowDuPont announced that it has completed the Health & Nutrition arm of FMC Corporation—other than its omega-3 business—to build on the former’s “sustainable, bio-based food ingredients” market share.
Pfizer announced that it is “reviewing strategic alternatives” for its Consumer Healthcare business, the parent company of many iconic over-the-counter (OTC) brands from dietary supplements to personal care.
The NASDAQ-traded firm Innophos Holdings has entered into a definitive merger agreement to acquire Novel Ingredients for $125m, bumping up the share of its food, health, and nutrition segment within the company.